Radwanski, Przemyslaw
- Ohio State University · Pharmacology (NIH department code)
- Ohio State University (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #11,395
- Rising Star
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2015 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pharmacology
NIH Funding · FY2023
Linked Award Amount
$917.7K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#11,395
By linked amount among FY2023 PIs
Earliest Year Loaded
2015
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Radwanski, Przemyslaw as a PI. Multi-PI records show the full award amount for context.
- 5R01HL155378-03R01Contact PIRegulation and dysregulation of sodium channels by by calmodulinOhio State University · Pharmacology (NIH department code)$492.9Kaward amount
- 5R01NS121234-02R01Contact PIDefining novel mechanisms of sudden death in Dravet syndrome: Dysregulation of sodium channels in the heart$424.8Kaward amount
Award organization
Organizations that administered FY2023 awards listing Radwanski, Przemyslaw as a PI.
FY2023 award administered by Ohio State University (OH).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2015First NIH AwardOhio State University
- 2017R01 Grant Holder
- 2018$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2022$2M Cumulative Funding